Email updates

Keep up to date with the latest news and content from BMC Research Notes and BioMed Central.

Open Access Research article

Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent

Laith N AL-Eitan1*, Saied A Jaradat2, Gary K Hulse34 and Guan K Tay1

Author Affiliations

1 Centre for Forensic Science, The University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia

2 Princess Haya Biotechnology Centre, Jordan University of Science and Technology, Irbid, 22110, Jordan

3 School of Psychiatry and Clinical Neurosciences, Queen Elizabeth II Medical Centre, The University of Western Australia, Crawley, WA, 6009, Australia

4 Unit for Research and Education in Alcohol and Drugs, Queen Elizabeth II Medical Centre, The University of Western Australia, Crawley, WA, 6009, Australia

For all author emails, please log on.

BMC Research Notes 2012, 5:497  doi:10.1186/1756-0500-5-497

Published: 10 September 2012

Abstract

Background

Both environmental and genetic factors contribute to individual susceptibility to initiation of substance use and vulnerability to addiction. Determining genetic risk factors can make an important contribution to understanding the processes leading to addiction. In order to identify gene(s) and mechanisms associated with substance addiction, a custom platform array search for a genetic association in a case/control of homogenous Jordanian Arab population was undertaken. Patients meeting the DSM-VI criteria for substance dependence (n = 220) and entering eight week treatment program at two Jordanian Drug Rehabilitation Centres were genotyped. In addition, 240 healthy controls were also genotyped. The sequenom MassARRAY system (iPLEX GOLD) was used to genotype 49 single nucleotide polymorphisms (SNPs) within 8 genes (DRD1, DRD2, DRD3, DRD4, DRD5, BDNF, SLC6A3 and COMT).

Results

This study revealed six new associations involving SNPs within DRD2 gene on chromosome 11. These six SNPs within the DRD2 were found to be most strongly associated with substance addiction in the Jordanian Arabic sample. The strongest statistical evidence for these new association signals were from rs1799732 in the C/−C promoter and rs1125394 in A/G intron 1 regions of DRD2, with the overall estimate of effects returning an odds ratio of 3.37 (χ2 (2, N = 460) = 21, p-value = 0.000026) and 1.78 (χ2 (2, N = 460) = 8, p-value = 0.001), respectively. It has been suggested that DRD2, dopamine receptor D2, plays an important role in dopamine secretion and the signal pathways of dopaminergic reward and drug addiction.

Conclusion

This study is the first to show a genetic link to substance addiction in a Jordanian population of Arab descent. These findings may contribute to our understanding of drug addiction mechanisms in Middle Eastern populations and how to manage or dictate therapy for individuals. Comparative analysis with different ethnic groups could assist further improving our understanding of these mechanisms.

Keywords:
SNP; DRD2; Opiates; Cocaine; Association; Substance addiction; Jordan; Arab